Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 33.41%212.6M | 13.28%753.62M | 7.19%506.29M | 0.22%322.13M | -6.52%159.36M | -17.33%665.28M | -11.73%472.32M | -12.86%321.42M | -6.63%170.47M | -4.98%804.74M |
Operating revenue | 33.41%212.6M | 13.28%753.62M | 7.19%506.29M | 0.22%322.13M | -6.52%159.36M | -17.33%665.28M | -11.73%472.32M | -12.86%321.42M | -6.63%170.47M | -4.98%804.74M |
Other operating revenue | ---- | -13.80%16.59M | ---- | 0.39%9.2M | ---- | 75.09%19.25M | ---- | 149.49%9.17M | ---- | 108.44%10.99M |
Total operating cost | 29.30%184.37M | 14.76%706.86M | 11.87%487.69M | 2.88%304.31M | -10.11%142.58M | -21.19%615.95M | -17.83%435.95M | -18.23%295.79M | -7.86%158.63M | 3.71%781.58M |
Operating cost | 30.42%106.58M | 19.69%400.2M | 11.07%266.51M | 3.94%164.41M | -0.75%81.72M | -18.94%334.36M | -14.53%239.95M | -17.55%158.18M | -12.70%82.33M | -3.64%412.5M |
Operating tax surcharges | 226.07%1.44M | 3.24%5.07M | -21.81%2.62M | -29.89%1.47M | -69.23%442.2K | -17.60%4.91M | -2.65%3.35M | -11.56%2.09M | 7.67%1.44M | 17.50%5.95M |
Operating expense | 53.38%55.31M | 16.48%209.5M | 19.63%145.43M | 4.28%91.6M | -21.33%36.06M | -29.03%179.85M | -27.65%121.57M | -21.68%87.84M | -4.57%45.84M | 17.12%253.43M |
Administration expense | -16.37%13.63M | -4.59%60.16M | -8.45%44.13M | -10.11%30.34M | -6.65%16.3M | -18.60%63.06M | -17.80%48.21M | -15.23%33.75M | -10.98%17.46M | 13.11%77.47M |
Financial expense | 15.40%-1.34M | -9.05%-6.84M | 83.93%-998.88K | 40.80%-3.54M | -610.15%-1.59M | -159.02%-6.27M | 5.48%-6.21M | -97.11%-5.97M | -67.20%310.97K | -150.25%-2.42M |
-Interest expense (Financial expense) | 64.82%684.42K | 4.54%2.7M | -6.23%1.88M | -30.43%1M | -47.56%415.24K | -25.10%2.59M | -19.07%2.01M | -10.13%1.44M | -0.30%791.77K | 5.43%3.45M |
-Interest Income (Financial expense) | -43.42%-2.15M | 19.40%-6.38M | 19.08%-4.68M | 22.71%-3.13M | 35.67%-1.5M | -322.47%-7.92M | -361.26%-5.78M | -350.81%-4.06M | -363.96%-2.33M | -13.72%-1.87M |
Research and development | -9.35%8.75M | -3.17%38.77M | 3.12%30.01M | 0.63%20.02M | -14.18%9.65M | 15.55%40.04M | 10.73%29.1M | 7.02%19.9M | 42.11%11.25M | 12.58%34.65M |
Credit Impairment Loss | 147.84%113.43K | -275.84%-559.16K | 146.99%105.54K | -160.49%-160.85K | -165.68%-237.1K | 63.29%317.99K | -161.01%-224.6K | -42.75%265.92K | -41.13%360.99K | 188.23%194.74K |
Asset Impairment Loss | 1,448.76%167.96K | -142.11%-520.64K | -50.16%607.33K | -82.46%264.19K | -101.29%-12.45K | 145.65%1.24M | 260.74%1.22M | 278.45%1.51M | --966.05K | -92.29%-2.71M |
Other net revenue | 9.81%10.2M | -6.77%27.3M | 5.97%21.93M | 7.49%16.38M | 18.59%9.29M | 11.14%29.28M | 2.14%20.7M | 4.04%15.24M | 31.51%7.84M | 0.85%26.35M |
Fair value change income | 50.05%-588.93K | -115.36%-254.79K | -147.57%-835.52K | -131.45%-605.62K | -206.62%-1.18M | 127.73%1.66M | -59.05%1.76M | -65.80%1.93M | -35.84%1.11M | 157.08%728.28K |
Invest income | -56.01%1.67M | -4.69%7.39M | 13.89%7M | 71.21%4.95M | 286.53%3.8M | 1,073.69%7.76M | 240.19%6.15M | 184.57%2.89M | 125.28%982.96K | -107.98%-796.58K |
Asset deal income | -182.77%-3.53K | 109.59%43.52K | -227.00%-104.51K | -116.04%-88.36K | 107.38%4.26K | -125.41%-453.9K | -27.55%82.29K | -17,105.91%-40.9K | ---57.68K | -167.11%-201.37K |
Other revenue | 27.85%8.84M | 12.95%21.2M | 29.38%15.16M | 38.30%12.03M | 54.49%6.92M | -35.57%18.77M | -43.23%11.72M | -32.13%8.7M | -40.38%4.48M | 55.33%29.13M |
Operating profit | 47.47%38.44M | -5.80%74.06M | -28.97%40.53M | -16.30%34.21M | 32.45%26.06M | 58.80%78.62M | 130.02%57.06M | 87.77%40.87M | 20.20%19.68M | -58.53%49.51M |
Add:Non operating Income | 504.75%139.72K | 26.47%595.83K | -41.48%254.79K | 40.66%184.86K | -55.25%23.1K | -74.93%471.12K | -69.25%435.37K | -85.54%131.43K | -76.88%51.63K | 78.64%1.88M |
Less:Non operating expense | 11.45%193.33K | -26.44%453.51K | -15.70%405.25K | -8.05%368.05K | 708.25%173.47K | -47.45%616.51K | -30.90%480.74K | -39.60%400.27K | -92.63%21.46K | -65.08%1.17M |
Total profit | 48.12%38.38M | -5.44%74.2M | -29.18%40.38M | -16.20%34.02M | 31.48%25.91M | 56.28%78.47M | 123.35%57.02M | 84.44%40.6M | 20.89%19.71M | -57.11%50.21M |
Less:Income tax cost | 50.93%5.01M | -34.05%4.69M | -67.87%1.5M | -29.01%2.11M | 58.69%3.32M | 119.38%7.12M | 493.41%4.66M | 635.44%2.97M | 1,453.94%2.09M | -62.28%3.24M |
Net profit | 47.71%33.37M | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M |
Net profit from continuing operation | 47.71%33.37M | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M |
Net profit of parent company owners | 47.71%33.37M | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M |
Earning per share | ||||||||||
Basic earning per share | 48.70%0.1029 | -2.24%0.2138 | -25.50%0.1195 | -15.09%0.0979 | 28.15%0.0692 | 51.88%0.2187 | 95.85%0.1604 | 66.62%0.1153 | 6.93%0.054 | -56.72%0.144 |
Diluted earning per share | 48.70%0.1029 | -2.24%0.2138 | -25.50%0.1195 | -15.09%0.0979 | 28.15%0.0692 | 51.88%0.2187 | 95.85%0.1604 | 66.62%0.1153 | 6.93%0.054 | -56.72%0.144 |
Other composite income | ||||||||||
Total composite income | 47.71%33.37M | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M |
Total composite income of parent company owners | 47.71%33.37M | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.